SEARCH

SEARCH BY CITATION

References

  • Bae S., Bessho Y., Hojo M. and Kageyama R. (2000) The bHLH gene Hes6, an inhibitor of Hes1, promotes neuronal differentiation. Development 127, 29332943.
  • Blochl A. and Blochl R. (2007) A cell-biological model of p75NTR signaling. J. Neurochem. 102, 289305.
  • Bui N. T., Livolsi A., Peyron J. F. and Prehn J. H. (2001) Activation of nuclear factor kappaB and Bcl-x survival gene expression by nerve growth factor requires tyrosine phosphorylation of IkappaBalpha. J. Cell Biol. 152, 753764.
  • Cleary J. P., Walsh D. M., Hofmeister J. J., Shankar G. M., Kuskowski M. A., Selkoe D. J. and Ashe K. H. (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8, 7984.
  • Coulson E. J. (2006) Does the p75 neurotrophin receptor mediate a beta-induced toxicity in Alzheimer’s disease? J. Neurochem. 98, 654660.
  • DeRosa R., Garcia A. A., Braschi C., Capsoni S., Maffei L., Berardi N. and Cattaneo A. (2005) Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc. Natl Acad. Sci. USA 102, 38113816.
  • Franklin J. L., Berechid B. E., Cutting F. B., Presente A., Chambers C. B., Foltz D. R., Ferreira A. and Nye J. S. (1999) Autonomous and non-autonomous regulation of mammalian neurite development by Notch1 and Delta1 24. Curr. Biol. 9, 14481457.
  • Goslin K. and Banker G. (1989) Experimental observations on the development of polarity by hippocampal neurons in culture. J. Cell Biol. 108, 15071516.
  • Hashimoto Y., Kaneko Y., Tsukamoto E. et al. (2004) Molecular characterization of neurohybrid cell death induced by Alzheimer’s amyloid-beta peptides via p75NTR/PLAIDD. J. Neurochem. 90, 549558.
  • Jin X., Hu H., Mathers P. H. and Agmon A. (2003) Brain-derived neurotrophic factor mediates activity-dependent dendritic growth in nonpyramidal neocortical interneurons in developing organotypic cultures. J. Neurosci. 23, 56625673.
  • Kaltschmidt B., Uherek M., Wellmann H., Volk B. and Kaltschmidt C. (1999) Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. Proc. Natl Acad. Sci. USA 96, 94099414.
  • Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S. and Malinow R. (2003) APP processing and synaptic function. Neuron 37, 925937.
  • Lipton S. A. and Rosenberg P. A. (1994) Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330, 613622.
  • Liu G. (2004) Local structural balance and functional interaction of excitatory and inhibitory synapses in hippocampal dendrites 10530. Nat. Neurosci. 7, 373379.
  • Louzada P. R., Lima A. C., Mendonca-Silva D. L., Noel F., De Mello F. G. and Ferreira S. T. (2004) Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer’s disease and other neurological disorders. FASEB J. 18, 511518.
  • Memet S. (2006) NF-kappaB functions in the nervous system: from development to disease. Biochem. Pharmacol. 72, 11801195.
  • Mukhopadhyay A., Manna S. K. and Aggarwal B. B. (2000) Pervanadate-induced nuclear factor-kappa B activation requires tyrosine phosphorylation and degradation of ikappa balpha. Comparison with tumor necrosis factor-alpha. J. Biol. Chem. 275, 85498555.
  • Peng S., Wuu J., Mufson E. J. and Fahnestock M. (2004) Increased proNGF levels in subjects with mild cognitive impairment and mild Alzheimer disease. J. Neuropathol. Exp. Neurol. 63, 641649.
  • Perini G., La-Bianca V., Politi V., Della V. G., Dal-Pra I., Rossi F. and Armato U. (2002) Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J. Exp. Med. 195, 907918.
  • Rabizadeh S., Oh J., Zhong L. T., Yang J., Bitler C. M., Butcher L. L. and Bredesen D. E. (1993) Induction of apoptosis by the low-affinity NGF receptor. Science 261, 345348.
  • Rabizadeh S., Bitler C. M., Butcher L. L. and Bredesen D. E. (1994) Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc. Natl Acad. Sci. USA 91, 1070310706.
  • Redmond L., Oh S. R., Hicks C., Weinmaster G. and Ghosh A. (2000) Nuclear Notch1 signaling and the regulation of dendritic development 4. Nat. Neurosci. 3, 3040.
  • Religa D., Laudon H., Styczynska M., Winblad B., Naslund J. and Haroutunian V. (2003) Amyloid beta pathology in Alzheimer’s disease and schizophrenia. Am. J. Psychiatry 160, 867872.
  • Salama-Cohen P., Arevalo M. A., Meier J., Grantyn R. and Rodriguez-Tebar A. (2005) NGF controls dendrite development in hippocampal neurons by binding to p75NTR and modulating the cellular targets of Notch. Mol. Biol. Cell 16, 339347.
  • Salama-Cohen P., Arevalo M. A., Grantyn R. and Rodriguez-Tebar A. (2006) Notch and NGF/p75NTR control dendrite morphology and the balance of excitatory/inhibitory synaptic input to hippocampal neurones through Neurogenin 3. J. Neurochem. 97, 12691278.
  • Selkoe D. J. (2004) Alzheimer disease: mechanistic understanding predicts novel therapies. Ann. Intern. Med. 140, 627638.
  • Sestan N., Rtavanis-Tsakonas S. and Rakic P. (1999) Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. Science 286, 741746.
  • Singh B., Henneberger C., Betances D., Arevalo M. A., Rodriguez-Tebar A., Meier J. C. and Grantyn R. (2006) Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons. J. Neurosci. 26, 71897200.
  • Susen K. and Blochl A. (2005) Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75. J. Mol. Med. 83, 720735.
  • Tuszynski M. H., Thal L., Pay M. et al. (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat. Med. 11, 551555.
  • Valerio A., Boroni F., Benarese M., Sarnico I., Ghisi V., Bresciani L. G., Ferrario M., Borsani G., Spano P. and Pizzi M. (2006) NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production. Eur. J. Neurosci. 23, 17111720.
  • Volosin M., Song W., Almeida R. D., Kaplan D. R., Hempstead B. L. and Friedman W. J. (2006) Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J. Neurosci. 26, 77567766.
  • Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J. and Selkoe D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535539.
  • Walsh D. M., Townsend M., Podlisny M. B., Shankar G. M., Fadeeva J. V., Agnaf O. E., Hartley D. M. and Selkoe D. J. (2005) Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation. J. Neurosci. 25, 24552462.
  • Wellmann H., Kaltschmidt B. and Kaltschmidt C. (2001) Retrograde transport of transcription factor NF-kappa B in living neurons. J. Biol. Chem. 276, 1182111829.
  • Yaar M., Zhai S., Pilch P. F., Doyle S. M., Eisenhauer P. B., Fine R. E. and Gilchrest B. A. (1997) Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer’s disease. J. Clin. Invest. 100, 23332340.
  • Yaar M., Zhai S., Fine R. E., Eisenhauer P. B., Arble B. L., Stewart K. B. and Gilchrest B. A. (2002) Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J. Biol. Chem. 277, 77207725.
  • Yankner B. A., Duffy L. K. and Kirschner D. A. (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science 250, 279282.